Thrombosis and Hemostasis for 2009. The theme for this issue,''Laboratory Diagnostics and
Therapy in Thrombosis and Hemostasis: From Bedside to Bench to Bedside,''arose from two …

Next-generation (or massively parallel) sequencing has rapidly supplanted traditional
Sanger sequencing as the preferred methodology for acquiring clinical sequence data …

The arrival of genomic medicine was presaged by the publication of the draft human
genome sequence in 2001. 1, 2 Now, the application of genome-scale sequencing is being …

There has been an exponential growth in the performance and output of sequencing
technologies (omics data) with full genome sequencing now producing gigabases of reads …

Human genomic sequencing has potential diagnostic, prognostic, and therapeutic value
across a wide breadth of clinical disciplines. One barrier to widespread adoption is the …

Technological breakthroughs in sequencing technologies have driven the advancement of
molecular biology and molecular genetics research. The advent of high-throughput Sanger …

Human genome sequencing is the process by which the exact order of nucleic acid base
pairs in the 24 human chromosomes is determined. Since the completion of the Human …

Despite knowledge of various inherited risk factors associated with venous
thromboembolism (VTE), no definite cause can be found in about 50% of patients. The …

Most physicians believe they practiced personalized medicine prior to the genomics era that
followed the sequencing of the human genome. The focus of personalized medicine has …

This invited review follows the oral presentation" To Sequence or Not to Sequence, That Is
Not the Question; But" When, Who, Which and What For?" Is “given during the State Of the …